Showing results (41-50 of 140) with videos related to
Sort By:
Pageof 14
The Journal of Experimental Medicine|October 1, 1986
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunityA DiGiacomo, R J NorthImmunology|March 1, 1987
Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumourA Digiacomo, R J NorthInternational Journal of Cancer|February 15, 1986
Immunological consequences of tumor excision: from active immunity to immunological memoryI Bursuker, R J NorthThe Journal of Experimental Medicine|December 1, 1988
Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunityM Awwad, R J NorthCancer Immunology, Immunotherapy : CII|January 1, 1985
Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donorsI Bursuker, R J NorthImmunology|May 8, 1999
Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccinationE Medina, R J NorthThe Journal of Experimental Medicine|May 1, 1984
Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cellsR J North, I BursukerCancer Research|April 15, 1990
Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumorsM Awwad, R J NorthThe Journal of Experimental Medicine|March 1, 1996
Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosisE Medina, R J NorthPageof 14